Caveolae-mediated endocytic machinery

Caveolae-mediated endocytic machinery refers to the specialized cellular apparatus responsible for the formation and internalisation of caveolae, which are 50-100 nm flask-shaped invaginations of the plasma membrane (PubMed: 21403647). This machinery is primarily composed of integral membrane proteins called caveolins (CAV1, CAV2, CAV3) and peripheral membrane proteins known as cavins, which stabilize the membrane curvature and facilitate vesicle scission (UniProt: Q03135). Beyond its role in the uptake of specific ligands like albumin and certain vitamins, this pathway is a critical regulator of signal transduction, lipid metabolism, and cellular responses to mechanical stress (PubMed: 24403030). In clinical medicine, the machinery is a significant target for drug delivery, particularly for albumin-conjugated chemotherapeutics that exploit caveolar transcytosis to penetrate the vascular endothelium and reach tumor tissues (PubMed: 18337447). Conversely, dysregulation of this machinery is implicated in various pathologies, including muscular dystrophies, cardiovascular diseases, and cancer progression, where caveolins can act as either tumor suppressors or oncogenes depending on the cellular context (PubMed: 15378057). The machinery is also exploited by various pathogens, including certain viruses and bacteria, as a route for cellular entry that bypasses lysosomal degradation.

Other names

Caveolar endocytosisCaveolae-dependent endocytosisCaveolae-mediated uptakeCaveolar pathwayPlasmalemmal vesicles

Therapeutic agents like albumin-bound paclitaxel utilize the gp60 receptor-mediated activation of this machinery to facilitate transcytosis across endothelial barriers (PubMed: 18337447). Conversely, experimental inhibitors like filipin and nystatin disrupt the machinery by sequestering membrane cholesterol, which is essential for the structural integrity of caveolae (PubMed: 10359518).